BIND Therapeutics' Asset Sale

BIND Therapeutics raised a round of funding on July 28, 2016. Investors include Pfizer.

BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its Medicinal Nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal Nano…

Articles about BIND Therapeutics' Asset Sale: